Long Acting Antibody (LAAB) to prevent COVID-19 is injected into immunosuppressed patients, such as chronic renal failure patients who receivekidney dialysis, organ or bone marrow transplanters receiving immunosuppressant drugs By pilot injection at Bamrasnaradura Institute today is the first day. It is safe to protect for 6 months, while the general public still need to get a booster. And intensify preventive measures to help fight BA.4/BA.5
On July 27, 2022 at Bamrasnaradura Institute, Nonthaburi Province, Mr. Anutin Charnvirakul Deputy Prime Minister and Minister of Public Health Presided over the first day of organizing the Long Acting Antibody (LAAB) pilot to prevent COVID-19 for patients with immune system problems, with Dr. Kiatpoom Wongrachit, Permanent Secretary of the Ministry of Public Health, and Dr. Opas Karnkawin. pong Director-General of the Department of Disease Control attended
Mr. Anutin said from the forecast Thailand has more than 500,000 immunocompromised patients, and now 7 thousand doses of Long Acting Antibody (LAAB) for patients with immune system problems. arrived in Thailand on July 25 From the order of 2.5 hundred thousand doses, the rest will be gradually delivered until complete within this year. For the first lot, it will be distributed to various provinces across the country for injections for chronic renal failure patients undergoing dialysis. People who have received an organ transplant or bone marrow receiving immunosuppressant medication. according to the patient information collected and delivered which each province will continue to distribute to various hospitals to be able to receive the service as conveniently as possible
“Confirm that medical personnel are ready to use the indicated immunity. because they have been trained to understand in the same direction and asked for cooperation from all medical and public health personnel to administer the LAAB injections by considering the injections to be equitable. and the greatest benefit to the people and observe symptoms following receiving standard LAAB,” Mr Anutin said.
Mr. Anutin continued that today is the first day as a pilot project of giving LAAB to chronic renal failure patients. to build confidence LAAB immunosuppressants are packaged in two bottles of two antibodies, which are injected into the patient’s hip at the same time on both sides. One injection has been shown to be effective in preventing coronavirus for approximately 6 months, confirming that LAAB is safe and It reduces the risk of infection, severe symptoms and death for patients with immune system problems. The target groups can contact to receive LAAB injections at hospitals as specified by the Provincial Communicable Disease Committee/Bangkok. From August 1, 2022 onwards. In addition, the manufacturer is in the process of collecting information for registration. FDA to be used in further treatment.
“For the general public, emphasize that Ask them to come in to receive the booster vaccination as scheduled. Which can be injected every 3-4 months to increase immunity to be able to fight the virus. Since most of the species are now BA.4/BA.5, which from the study of the Department of Medical Sciences found that It is better to avoid immunity than the BA.2 strain, therefore, it is necessary to be vaccinated together with strict measures to prevent infection, namely social distancing, washing hands, wearing masks and testing for ATK when symptoms are present or at risk,” Mr Anutin said.
Dr. Kiattipoom said that The Ministry of Public Health has a policy to provide a vaccine for COVID-19 to reduce the severity and death of COVID-19, starting from February 2021, over 1 year and 5 months ago. Medical and public health personnel have accelerated the provision of the COVID-19 vaccine to all target populations. More than 141 million doses have been vaccinated so far, but there are some people with low immunity. The body is unable to build immunity by vaccination, such as dialysis patients. organ transplant patient group bone marrow transplant or immunocompromised groups, etc., resulting in a risk of serious illness or death if infected with COVID-19, so LAAB long-acting antibodies have been provided to be injected before exposure to the coronavirus to such target groups. LAAB is currently in the process of shipping to all areas for the fastest service possible.
